In contrast to drugs like cocaine or marijuana, psychedelics are strong and give users access to a kind of "alternate reality ...

ACADIA Pharmaceuticals Inc (ACAD) reports a 32% annual revenue increase, driven by strong sales of DAYBUE and NUPLAZID, while expanding its pipeline and preparing for European market entry.

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...

For teenagers who do not respond to serotonergic medications or CBT, doctors may also consider other types of medication, such as atypical antipsychotics. Researchers have also analyzed the ...

Jason Najum talks to Srinivas Rao, CEO of Atai Life Sciences, a biotech company focused on mental health and psychedelic compounds.

What I find most exciting about NUPLAZID's sales performance is that we still only have about a 25% market share in those patients receiving atypical antipsychotics for the treatment of Parkinson ...

Talk about a heavy dose. While the bulk of news coverage is focused on GLP-1 drugs like Ozempic that cause weight loss, ...

Paranoid symptoms and severe aggression, which represent a danger to the individual and to others, warrant the use of atypical antipsychotics after their relative risks and benefits have been ...

“The typical antipsychotics (ie, first generation) and atypical antipsychotics make patients more susceptible to TD, but at a reduced incidence,” explains Dr. Weeks. The most widely accepted mechanism ...

There’s a lot I didn’t understand about taking antipsychotic medication. Sedation is one of the most common side effects of atypical antipsychotics — and for me, it’s the worst. I didn’t realize just ...